CausalSentinel

Protein Dossier — IGFBP1 (Insulin-like growth factor-binding protein 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Triglycerides 0.731 0.0217 6.50e-250 Wald ratio 1 trans NA
Non-cancer illness code self-reported: gout 0.884 0.0548 1.38e-58 Wald ratio 1 trans NA
Total cholesterol 0.326 0.0229 6.67e-46 Wald ratio 1 trans NA
Urate 0.49 0.035 1.56e-44 Wald ratio 1 trans NA
Non-cancer illness code self-reported: high cholesterol 0.398 0.0286 7.29e-44 Wald ratio 1 trans NA
Alcohol intake frequency 0.294 0.0233 1.26e-36 Wald ratio 1 trans NA
Fasting glucose -0.204 0.0197 5.57e-25 Wald ratio 1 trans NA
Crohn’s disease 0.73 0.0767 1.74e-21 Wald ratio 1 trans NA
Inflammatory bowel disease 0.491 0.0635 1.03e-14 Wald ratio 1 trans NA
Sodium in urine 0.119 0.0155 2.00e-14 Wald ratio 1 trans NA
Weight -0.103 0.0139 1.05e-13 Wald ratio 1 trans NA
Serum creatinine (eGFRcrea) 0.0433 0.00586 1.45e-13 Wald ratio 1 trans NA
…and 135 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2771_35_2 IGFBP-1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

11 association rows across 8 traits (10 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Height 2e-30 rs1496496 1 GCST90245848 MR: beta=-0.127, p=2.62e-11 (trans)
IGFBP3 protein levels 5e-29 rs9658222 4 GCST90469529 no MR -> candidate analysis
Circulating IGFBP1 levels 6e-26 rs2331390 1 GCST90859951 no MR -> candidate analysis
IGFBP1 protein levels 7e-14 rs28705240 1 GCST90469527 no MR -> candidate analysis
Insulin-like growth factor-binding protein 1 levels 1e-12 rs10577484 1 GCST90248010 no MR -> candidate analysis
Myocardial infarction 3e-8 rs117054298 1 GCST90018877 no MR -> candidate analysis
Blood pressure (pleiotropy model 1 DBP adjusted for estimate 4e-8 rs10282088 1 GCST90239828 no MR -> candidate analysis
Blood pressure (pleiotropy model 2 SBP adjusted for estimate 1e-7 rs10282088 1 GCST90239829 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 708 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Abnormality of the skeletal system 0.147 common-variant locus no MR -> candidate analysis
cataract 0.139 common-variant locus MR: beta=0.165, p=0.0247 (trans)
Epidermal Inclusion Cyst 0.117 common-variant locus no MR -> candidate analysis
tenosynovitis 0.117 common-variant locus no MR -> candidate analysis
senile cataract 0.11 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Insulin-like growth factor-binding protein 1)
gnomAD constraint pLI=1e-13, LOEUF=1.81 — LoF-tolerant
GWAS Catalog 83 unique SNPs / 166 rows
ClinVar 63 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance